INNATE PHARMA SA-SPONS ADR (IPHA) Stock Cash Flow
NASDAQ:IPHA - Nasdaq - US45781K2042 - ADR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.05M | -7.57M | -58.10M | -52.81M | -63.98M | |||
| Depreciation Amortization | 2.59M | 5.09M | 45.41M | 4.60M | 56.80M | |||
| Change In Working Capital | 13.04M | -32.09M | -12.50M | -9.57M | -48.87M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 312.00K | 341.00K | |||
| Other non cash items | 371.00K | 2.01M | 6.05M | -672.00K | 4.28M | |||
| OPERATING CASH FLOW | -18.06M | -32.56M | -19.15M | -58.45M | -51.77M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.33M | -2.35M | -1.12M | -1.33M | -11.34M | |||
| Other Investing Activity | 24.13M | 22.98M | 3.00M | 414.00K | -2.03M | |||
| INVESTING CASH FLOW | 21.81M | 20.63M | 1.88M | -917.00K | -13.37M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.19M | -2.36M | -2.03M | 26.63M | -885.00K | |||
| Stock Issued/Repurchased | 140.00K | 395.00K | 198.00K | 499.00K | 48.00K | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -312.00K | -340.00K | |||
| FINANCING CASH FLOW | -5.05M | -1.97M | -1.83M | 26.82M | -1.18M | |||
| Exchange Rate Effect | -128.00K | 274.00K | -428.00K | -483.00K | 219.00K | |||
| CHANGE IN CASH | -1.42M | -13.62M | -19.53M | -33.04M | -66.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.06M | -32.56M | -19.15M | -58.45M | -51.77M | |||
| Capital Expenditure | -2.33M | -2.35M | -1.12M | -1.33M | -11.34M | |||
| FREE CASH FLOW | -20.38M | -34.91M | -20.28M | -59.79M | -63.11M | |||
All data in EUR